On 26 July 2017, Abano Healthcare Group LImited announced a fully underwritten 1 for 5 pro-rata renounceable rights offer and a shortfall bookbuild to raise approximately $35 million.

The net proceeds of the offer will be used to provide additional headroom and flexibility for Abano to respond to the increased acquisition opportunity and step up its growth plans in the trans-Tasman dental market,  particularly in Australia.

Under the offer, eligible shareholders are entitled (but not obliged) to subscribe for 1 new share for every 5 existing shares held as at 5.00pm on the record date of 3 August 2017, at an issue price of $8.15 per new share. This represents a 13.3% discount to the
dividend adjusted closing price of $9.40 per share, based on the 25 July 2017 closing price.



Rights Offer Document

Letter to Shareholders

FY17 Results and Capital Raising Presentation



Capital Raising Announcement: 26 July 2017

Distribution of Offer Document: 4 August 2017

Reminder Letter to Shareholders re Rights Offer: 16 August 2017

Abano Closes Rights Offer and Commences Shortfall Bookbuild: 25 August 2017

Abano Announces Completion of Shortfall Bookbuild: 28 August 2017